Yili Chuanning (China) Top Management

301301 Stock   12.92  0.08  0.62%   
Yili Chuanning employs about 2.9 K people. The company is managed by 2 executives with a total tenure of roughly 6723 years, averaging almost 3361.0 years of service per executive, having 1440.5 employees per reported executive. Analysis of Yili Chuanning's management performance can provide insight into the company performance.
Xuheng Deng  Executive
Secretary GM
Zhao Hua  Executive
Deputy Scientist
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yili Chuanning Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Yili Chuanning Workforce Comparison

Yili Chuanning Biotechnology is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2.8 Million. Yili Chuanning adds roughly 2,881 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.24 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Yili Chuanning Biote Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Yili Chuanning Biote Price Series Summation is a cross summation of Yili Chuanning price series and its benchmark/peer.

Yili Chuanning Notable Stakeholders

A Yili Chuanning stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Yili Chuanning often face trade-offs trying to please all of them. Yili Chuanning's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Yili Chuanning's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Xuheng DengSecretary GMProfile
Zhao HuaDeputy ScientistProfile

About Yili Chuanning Management Performance

The success or failure of an entity such as Yili Chuanning Biote often depends on how effective the management is. Yili Chuanning management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Yili management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Yili management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Yili Chuanning is entity of China. It is traded as Stock on SHE exchange.
Please note, the presentation of Yili Chuanning's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Yili Chuanning's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Yili Chuanning's management manipulating its earnings.

Yili Chuanning Workforce Analysis

Traditionally, organizations such as Yili Chuanning use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Yili Chuanning within its industry.

Yili Chuanning Manpower Efficiency

Return on Yili Chuanning Manpower

Revenue Per Employee2M
Revenue Per Executive2.8B

Complementary Tools for Yili Stock analysis

When running Yili Chuanning's price analysis, check to measure Yili Chuanning's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yili Chuanning is operating at the current time. Most of Yili Chuanning's value examination focuses on studying past and present price action to predict the probability of Yili Chuanning's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yili Chuanning's price. Additionally, you may evaluate how the addition of Yili Chuanning to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies